We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » China Investigating Drug Pricing At Domestic, Multinational Firms
China Investigating Drug Pricing At Domestic, Multinational Firms
July 10, 2013
The Chinese government is conducting a review of drug pricing and manufacturing costs at selected domestic and international companies, with an eye on making healthcare more accessible to its people.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor